OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
Go back to OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections| OraSure Technologies, Inc. (NASDAQ: OSUR) | Delayed: 4.19 +0.03 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.16 | 52 Week High | $9.05 | |||
| Open | $4.12 | 52 Week Low | $5.10 | |||
| Day High | $4.27 | P/E | N/A | |||
| Day Low | $4.11 | EPS | $-0.20 | |||
| Volume | 309,177 | |||||
